Table 4.
Study | New cut-off point (mg/mmol) | New sensitivity (%) | New specificity (%) | New likelihood ratio | |
---|---|---|---|---|---|
Positive | Negative | ||||
Al et al 2004w1 | 22.6 | 80 | 74 | 3.08 | 0.27 |
Durnwald et al 2003w2 | 33.9 | 81.0 | 55.8 | 1.83 | 0.34 |
Ramos et al 1999w5 | 30 | 94 | 80 | 4.7 | 0.08 |
Rodriguez-Thompson et al 2001w7 | 30 | 83 | 71 | 2.86 | 0.24 |
Saudan et al 1997w8 | 30 | 93 | 92 | 11.63 | 0.08 |
Taherian et al 2006w9 | 22.6 | 80.8 | 100 | Infinity | 0.19 |
Wheeler et al 2007w11 | 23.7 | 86.8 | 77.6 | 3.88 | 0.17 |
Yamasmit et al 2004w12 | 31.6 | 93.1 | 92.3 | 12.09 | 0.07 |
Young et al 1996w13 | 28.3 | 65 | 82 | 3.61 | 0.43 |